RumeyzaKazancioglu TürkiyeBezmialem Vakif University

• Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
  VijiNair Speaker United States
• Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
  MatthiasKretzler Speaker kretzler@umich.eduUnited StatesUniversity of Michigan
• The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
  JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University
• Panel Discussion

• My Story
  VictoriaGray Speaker vwright_03@yahoo.comUnited States
• CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
  Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja

• How to Achieve Transparent and Regulated Organ Donation and Transplantation
  Maria AmaliaMatamoros Speaker amatamoros@cehcr.comCosta RicaCaja Costarricense del Seguro social
• Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism
  LilianaBisigniano Speaker lbisigniano@incucai.gov.arArgentinaLiliana Bisigniano MD
• How to Handle Cases of Presumed Transplant Tourism
  KenSakai Speaker JapanDepartment of Nephrology, Toho University Omori Medical Center
• Q and A

• Big Data Lab
  LAB-01
• Patient-reported Outcome Measures: How Do Patients Experience CKD?
  AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care
• Trial Simulation Using Observational Data
  AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health
• Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
  DorotheaNitsch Speaker United KingdomLondon School of Hygiene & Tropical Medicine
• Q and A

• Update of Glomerulonephritis
  FernandoFervenza Speaker fervenza.fernando@mayo.eduUnited StatesMayo Clinic
• Inflammation and Metabolic Kidney Disease
  JunWada Speaker JapanOkayama University
• A Novel Treatment Targeting Kidney Inflammation
  Maria JoseSoler Speaker mjsoler01@gmail.comSpainHospital del Vall d´Hebron
• Controlling Kidney Inflammation Through the Nervous System
  ShinjiTanaka Speaker JapanDivision of Nephrology and Endocrinology, the University of Tokyo Hospital
• Q and A

• Generative AI Revolution in Medicine
  MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/
• Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh)
  Mohammad Shakib Uz ZamanArefin Speaker Bangladesh

• The Next Pandemic - What Has the Nephrology Community Learned From COVID-19?
  RaulLombardi Speaker lombardi.raul2@gmail.comUruguayDepartment of Nephrology, Schoole of Medicine, Uni
• Challenges in Nephrological Care During Difficult Situations: Lessons From Venezuela
  Lorendiz Pamela Ronca Chacare Speaker lorendiz.ronca@gmail.comVenezuelaSociedad Venezolana de Nefrología
• Kidney Care During Earthquakes: Lessons Learned From Turkey
  RumeyzaKazancioglu Speaker drkazancioglu@yahoo.comTürkiyeBezmialem Vakif University
• Provision of Renal Care During Man-made Disasters and Armed Conflicts: A Challenging Proposition
  RobertNakhoul Najm Speaker robertnajem@yahoo.frLebanonLebanese University, Faculty of Medical Sciences.
• Q and A

• Use of Immunotherapy in Patients With Organ Transplants
  NaokaMurakami Speaker nmurakami1@bwh.harvard.eduUnited StatesBrigham and Women\'s Hospital, Harvard Medical S
• Transplantation Outcomes in Recipients with History of Cancer
  GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney
• Novel Strategies for Enhanced Organ Preservation during Machine Perfusion
  TobiasHuber Speaker t.huber@uke.deGermanyUniversity Medical Center Hamburg-Eppendorf
• Q and A

• Accessibility to CKD Diagnosis: Focus on CKDu (Chronic Kidney Disease of Unknown Origin) and Advancements in Diagnostic Approaches
  RamonGarcia Trabanino Speaker rgtrab@gmail.comEl SalvadorSLANH
• Latin American Dialysis and Renal Transplantation Registry: Updates and Progress
  MariaGonzalez Speaker registro@slanh.netUruguaySLANH
• Special Situations in Argentina: Addressing the Challenges Faced by Individuals on Dialysis Without a Diagnosis in the Argentinian Registry
  GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
• Cardiovascular and Renal Risk Factors in Argentinian First Nations: A Study of Qom and Wichi Indigenous Groups
  Maria Eugenia VictoriaBianchi Speaker bianchimaria@me.comArgentinaISN. SAN.
• Accessibility to Substitution Treatment in Latin America
  AlejandroFerreiro-Fuentes Speaker UruguayCentro de Nefrología. Universidad de la República,
• Accessibility to Programs of Prevention, and Early Detection and Treatment of Kidney Disease in Latin America
  Alfonso MartinCueto Manzano Speaker MexicoUnidad de Investigación Médica en Enfermedades Ren
• Break
• Panel Discussion and Closing Remarks by Valerie Luyckx, University of Zurich, Switzerland

• Patients Subphenotyping: The Example of Diabetic Kidney Disease
  John CijiangHe Speaker United StatesIcahn School of Medicine at Mount Sinai
• Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
  LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan
• Targeted Approaches in Clinical Trial Design
  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands
• Q and A

• Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism?
  John Funder Speaker John.Funder@hudson.org.auAustraliaThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria Australia
• Aldosterone and Disease
  JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania
• New Trials Using Aldosterone Synthese Blockade
  MichelAzizi Speaker michel.azizi@aphp.frFranceUniversité Paris Cité, Hypertension department, Hô
• Targeting MR for Heart and Kidney Protection
  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands
• Q and A

• Updates on IgAN Management
  HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES
• Membranous GN Classification and Management
  PierreRonco Speaker FranceHôpital Tenon
• MPGN Updates
  SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic
• Managing Vasculitis
  RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco
• Q and A

• Acceptance Speech: Bywaters Award
  MotokoYanagita Speaker JapanKyoto University
• Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture
  EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa
• ELP2 Graduation
  MasaomiNangaku Speaker JapanThe University of Tokyo

• Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS
  TaraChang Speaker United StatesStanford University
• Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS
  JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania